Dr. Amaria on Genetically Modified TILs in Melanoma
1 vistas
• 07/03/23
0
0
Empotrar
administrator
Suscriptores
Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios